QUICKSTRIP

Rapid Dose Therapeutics Inc.

Application Filed: 2018-10-21
Trademark Application Details
Trademark Logo QUICKSTRIP

The combined word "QuickStrip" with speed stripes to the left of the letter "Q", the word "Quick" in bold and the word "Strip" underlined.

Mark For: QUICKSTRIP™ trademark registration is intended to cover the categories of consulting in the field of orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the field of orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well being, nicotine and nicotine-polymer complexes; consulting in the field of orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the field of orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the field of orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diptheria, typhoid, meningitis, multiple schlerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration. [all]

>Color is not claimed as a feature of the mark. The combined word "QuickStrip" with speed stripes to the left of the letter "Q", the word "Quick" in bold and the word "Strip" underlined.

Status

2021-05-27 UTC
LIVE APPLICATION Opposition Pending
The pending trademark application has been examined by the Office and was published for opposition, at which time one or more oppositions were filed but they have not yet been decided.


Research OneLook Acronym Finder
Serial Number88163086
Mark Literal ElementsQUICKSTRIP
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeSERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-09-30
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 044 - Primary Class
  • (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisYes
Attorney NameTodd A. Van Thomme
Attorney Docket Number3009575-2014
Law Office AssignedL80
Employee NameLOOK, JEFFREY J

Timeline

2018-10-21Application Filed
2019-07-26Status: Live/Pending
2019-11-07Location: GENERIC WEB UPDATE
2019-11-20Transaction Date
2020-09-30Location: PUBLICATION AND ISSUE SECTION
2020-11-03Published
2021-05-03Status: An opposition after publication is pending at the Trademark Trial and Appeal Board. For further information, see TTABVUE on the

Trademark Parties (Applicants & Owners)

Party: Rapid Dose Therapeutics Inc.
AddressUnit 3 1121 Walkers Line Burlington, Ontario CANADA L7N2G4
Legal Entity TypeCorporation
Legal Entity StateCANADA

Documents

DrawingIMAGE/JPEG2018-10-21
TEAS RF New ApplicationAPPLICATION/XML,IMAGE/JPEG2018-10-21
Design Search Code Corr ProjectAPPLICATION/XML2018-11-02
Change of AddressXML2019-06-19
Offc Action OutgoingMULTI2019-07-26
XSearch Search SummaryXML2019-07-26
TEAS Rev, App and/or COA of Atty/Dom.RepXML2019-09-05
Administrative ResponseXML2019-11-07
Response to Office ActionAPPLICATION/XML,IMAGE/TIFF2020-01-24
Amendment and Mail Process CompleteMULTI2020-02-06
Offc Action OutgoingXML2020-03-18
Examiners AmendmentXML2020-09-29
Amendment and Mail Process CompleteMULTI2020-09-30
TRAM Snapshot of App at Pub for OppostnMULTI2020-10-01
Notice of PublicationXML2020-10-14
Notification Of Notice of PublicationXML2020-10-14
OG Publication ConfirmationAPPLICATION/XML2020-11-03

Design Search Codes

26.17.05Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal
26.17.13Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters
261701Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s)
261705Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal
261713Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters

Attorney of Record

Todd A. Van Thomme
Nyemaster Goode, P.C.
Suite 1600
700 Walnut Street
Des Moines IA 50309

Good, Services, and Codes


IC 044. US 100 101. G & S: Consulting in the field of orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the field of orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well being, nicotine and nicotine-polymer complexes; consulting in the field of orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the field of orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the field of orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diptheria, typhoid, meningitis, multiple schlerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:7
U.S. Codes:013,019,021,023,031,034,035
International Codes:44
U.S. Codes:100,101
Type CodeType
CC0000Color is not claimed as a feature of the mark.

Trademark Filing History

DescriptionDateProceeding Number
OPPOSITION INSTITUTED NO. 9999992021-05-03269101
EXTENSION OF TIME TO OPPOSE RECEIVED2020-11-18
PUBLISHED FOR OPPOSITION2020-11-03
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-11-03
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-10-14
APPROVED FOR PUB - PRINCIPAL REGISTER2020-09-30
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2020-09-296328
EXAMINERS AMENDMENT E-MAILED2020-09-296328
EXAMINERS AMENDMENT -WRITTEN2020-09-2972008
EXAMINER'S AMENDMENT ENTERED2020-09-2988888
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-03-186325
NON-FINAL ACTION WRITTEN2020-03-1872008
NON-FINAL ACTION E-MAILED2020-03-186325
TEAS/EMAIL CORRESPONDENCE ENTERED2020-02-0568123
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-02-0568123
ASSIGNED TO LIE2020-01-3068123
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-01-24
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN2019-11-2072008
LETTER OF PROTEST EVIDENCE FORWARDED2019-11-07
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-09-05
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-09-05
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-07-266325
NON-FINAL ACTION WRITTEN2019-07-2672008
NON-FINAL ACTION E-MAILED2019-07-266325
ASSIGNED TO EXAMINER2019-07-1972008
TEAS CHANGE OF CORRESPONDENCE RECEIVED2019-06-19
ASSIGNED TO EXAMINER2019-01-2888577
ASSIGNED TO EXAMINER2019-01-2594062
NOTICE OF DESIGN SEARCH CODE E-MAILED2018-11-02
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed